Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1422 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Taming big Pharma

By: MattB
Views: 1014

Pharmacist Opportunities Within a Pharmacy Benefit Manager

By: MattB
Views: 1103

FDA Role in Regulation of Cannabis Products

By: MattB
Views: 990

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

By: MattB
Views: 1128

Drug Payment Methodologies

By: MattB
Views: 1199

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

By: MattB
Views: 991

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

By: MattB
Views: 973

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

By: MattB
Views: 1010

Pharma 2020 Taxing times ahead

By: KhushbuSG
Views: 1183

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

By: MattB
Views: 1422

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z